Abstract
Ischemic heart disease is the most common chronic condition worldwide. Biomaterial patch implant into the infarcted epicardial surface has been applied as a possible treatment. Usual therapies result in a wide range of patients with post-ischemic heart failure, triggered by unfavorable ventricular remodeling. Moreover, the application of biodegradable scaffolds associated with platelet-ri…